期刊文献+

奥沙利铂联合亚叶酸钙、氟尿嘧啶治疗晚期结直肠癌的临床观察 被引量:4

下载PDF
导出
摘要 目的评价奥沙利铂(L-OHP)联合亚叶酸钙(CF)及氟尿嘧啶(5-FU)治疗晚期结直肠癌的疗效和毒副反应。方法51例晚期结直肠癌患者,给予L-OHP130mg/m^2静脉滴入,持续2h,第1天;CF:200mg/次,静脉滴入,持续2h,第2-6天;5-FU:500mg/m^2,静脉滴入,持续6h,第2-6天。每3周重复1次,用药2个周期后评价疗效。结果51例患者中,完全缓解(CR)2例,部分缓解(PR)17例,稳定(SD)20例,进展(PD)12例,总有效(CR+PR)率:37.2%。毒副反应主要是末梢神经毒性、恶心呕吐、骨髓抑制及静脉炎等。结论L-OHP联合CF/5-FU治疗晚期大肠癌具有较好的疗效,毒副反应可以耐受。
作者 陈楠 刘磊
出处 《中国实用医药》 2008年第22期130-131,共2页 China Practical Medicine
  • 相关文献

参考文献2

二级参考文献28

  • 1Higgens GA, Amadeo JH. Mc Elhinney J, et al. Efficacy of prolonged intermittent therapy combined 5 - fluorouracil and methyl - CCNU following resection for carcinoma of the large bowel [J] .Cancer,1984,53(1):1 - 8. 被引量:1
  • 2Rougier P, Sahmoud T, Nitti D, et al. Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Grupp 被引量:1
  • 3James RD. Intraportal 5-FU (PVI) and peri-operative radiotherapy (PT) in the adjuvant treatment of colorectal cancer ( CRCa) 3681 patients randomized in the UK. Coordination Committee on Cancer Research ( UKCCCR ) AXIS trial[C].Proc Am Soc Clin Oncol, 199 被引量:1
  • 4McArdle C, Kerr DJ, Ledermann JA, et al. Intravenous (IV) vs intrahepatic arterial (IHA) 5-FU/leucovorin for colorectal (CRC) liver metastases: preliminary results of the MRC CR05/EORTC 40972 randomised trial[C].Proc Am Soc Clin Oncol,2001,20:Abstract 499 被引量:1
  • 5Lorenz M, Muller HH. Randomized. multicenter trial of fluorouracil pins leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine adminstered via hepatic arterial infusion in patients with nonresctable liver met 被引量:1
  • 6Sadahiro S, Suzuki T, Tokunaga N. et al. Prophylactic hepatic arterial infusion chemotherapy for colon cancer patients without liver metastasis provides survival benefit[C].Proc Am Soc Clin Oncol,2001,20:Abstract 510. 被引量:1
  • 7Sakamoto J, Hamada C, Yasutomi M, et al. Adjuvant therapy with oral luormated pyrimidines after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials[C].Proc Am Sic Clin Oncol,2001,20 Abstract 583. 被引量:1
  • 8Levin J, Schilsky R, Burns H, et al. North American phase III study of oral eniluracil (EU) Plus oral 5-fluoronacil (5-FU) versus intravenous (IV) 5-FU plus leucovorin (LV) in the treatment of advanced colorectal cancer (ACC) [C].Proc Am Soc Clin Oncol, 2 被引量:1
  • 9Van Custem E, Sorensen J, Cassidy J, et al. International phase III study of oral eniluracil (EU) plus 5-fluorouracil (5-FU) versus intravenous (IV) 5- FU plus leucovorin (LV) in the treatment of advanced colorectal cancer[C].Proc Am Soc Clin Oncol,2001,2 被引量:1
  • 10Dollillard J-Y, Seitz J-F, A phase I study of oral uracil/tagafur (UFT) plus leucovorin combined with oxaliplatin in patients with metastatic colorectal cancer (ACRC) [C].Proc Am Soc Clin Oncol,2001,20: Abstract 572. 被引量:1

共引文献17

同被引文献29

  • 1徐建明,葛飞娇.转移性结直肠癌内科治疗进展[J].中国医学前沿杂志(电子版),2010,2(2):8-10. 被引量:1
  • 2秦新裕,许剑民,刘凤林,钟芸诗.进展期消化道肿瘤术前介入治疗的评价[J].中国实用外科杂志,2005,25(5):307-309. 被引量:13
  • 3孙燕,周际昌主编.临床肿瘤内科手册.第4版.北京:人民卫生出版社,2004.97. 被引量:2
  • 4茅爱武,程永德.重视对晚期肿瘤患者介入诊疗技术的应用[J].介入放射学杂志,2007,16(11):721-723. 被引量:8
  • 5Sadahiro S,Suzuki T,Ishikawa K. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years[J].Hepato-Gastroenterology,2003,(53):1362-1366. 被引量:1
  • 6Kemeny N,Gonen M,Sullivan D. Phase Ⅰ studyofhepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer[J].Journal of Clinical Oncology,2001,(10):2687-2695. 被引量:1
  • 7Adam R. Current surgical strategies for the treatment of colorect cancer liver metastascs[J].European Journal of Cancer,2004,(Suppl):21-26. 被引量:1
  • 8孙燕.内科肿瘤学[M]北京:人民卫生出版社,2001127. 被引量:1
  • 9Vogl TJ,Zango S,Balzer JO. Transarterial chemo embolization of liver metastases:Indication,technique,results[J].Rofo:Fortschritte Auf Dem Gebiete der Rontgenstrahlen Und der Nuklearmedizin,2002,(06):675-683. 被引量:1
  • 10Sakanmoto J,Clin K,Kondo K. Phase Ⅱ study of a 4 week capecitabineregimen in advanced or recurrent gastric cancer[J].Anti-Cancer Drug Design,2006,(02):231-236. 被引量:1

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部